Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors

The human recombinant G-CSF filgrastim has been widely used for the mobilization of CD34(+) stem cells of healthy donors (HD). In 2008, the G-CSF biosimilar XM02 (Ratiograstim, Tevagrastim and Biograstim) was approved by the European Medicines Agency (EMA) for the mobilization of PBSC. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, M, Xu, X, Hilgendorf, I, Schneider, C, Borchert, K, Gläser, D, Freund, M, Schmitt, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701262/
https://www.ncbi.nlm.nih.gov/pubmed/23318540
http://dx.doi.org/10.1038/bmt.2012.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701262/
https://www.ncbi.nlm.nih.gov/pubmed/23318540
http://dx.doi.org/10.1038/bmt.2012.270

Ejemplares similares